139 related articles for article (PubMed ID: 32900774)
21. Hyperglycaemia induces metabolic reprogramming into a glycolytic phenotype and promotes epithelial-mesenchymal transitions via YAP/TAZ-Hedgehog signalling axis in pancreatic cancer.
Liu Z; Hayashi H; Matsumura K; Ogata Y; Sato H; Shiraishi Y; Uemura N; Miyata T; Higashi T; Nakagawa S; Mima K; Imai K; Baba H
Br J Cancer; 2023 Mar; 128(5):844-856. PubMed ID: 36536047
[TBL] [Abstract][Full Text] [Related]
22. An evolutionarily conserved negative feedback mechanism in the Hippo pathway reflects functional difference between LATS1 and LATS2.
Park GS; Oh H; Kim M; Kim T; Johnson RL; Irvine KD; Lim DS
Oncotarget; 2016 Apr; 7(17):24063-75. PubMed ID: 27006470
[TBL] [Abstract][Full Text] [Related]
23. YAP in pancreatic cancer: oncogenic role and therapeutic strategy.
Mao W; Mai J; Peng H; Wan J; Sun T
Theranostics; 2021; 11(4):1753-1762. PubMed ID: 33408779
[TBL] [Abstract][Full Text] [Related]
24. LATS-YAP/TAZ controls lineage specification by regulating TGFβ signaling and Hnf4α expression during liver development.
Lee DH; Park JO; Kim TS; Kim SK; Kim TH; Kim MC; Park GS; Kim JH; Kuninaka S; Olson EN; Saya H; Kim SY; Lee H; Lim DS
Nat Commun; 2016 Jun; 7():11961. PubMed ID: 27358050
[TBL] [Abstract][Full Text] [Related]
25. Fbxw7 Deletion Accelerates Kras
Zhang Q; Zhang Y; Parsels JD; Lohse I; Lawrence TS; Pasca di Magliano M; Sun Y; Morgan MA
Neoplasia; 2016 Nov; 18(11):666-673. PubMed ID: 27764699
[TBL] [Abstract][Full Text] [Related]
26. Nicotine promotes initiation and progression of KRAS-induced pancreatic cancer via Gata6-dependent dedifferentiation of acinar cells in mice.
Hermann PC; Sancho P; Cañamero M; Martinelli P; Madriles F; Michl P; Gress T; de Pascual R; Gandia L; Guerra C; Barbacid M; Wagner M; Vieira CR; Aicher A; Real FX; Sainz B; Heeschen C
Gastroenterology; 2014 Nov; 147(5):1119-33.e4. PubMed ID: 25127677
[TBL] [Abstract][Full Text] [Related]
27. Hippo transducer TAZ promotes epithelial mesenchymal transition and supports pancreatic cancer progression.
Xie D; Cui J; Xia T; Jia Z; Wang L; Wei W; Zhu A; Gao Y; Xie K; Quan M
Oncotarget; 2015 Nov; 6(34):35949-63. PubMed ID: 26416426
[TBL] [Abstract][Full Text] [Related]
28. YAP-TEAD signaling promotes basal cell carcinoma development via a c-JUN/AP1 axis.
Maglic D; Schlegelmilch K; Dost AF; Panero R; Dill MT; Calogero RA; Camargo FD
EMBO J; 2018 Sep; 37(17):. PubMed ID: 30037824
[TBL] [Abstract][Full Text] [Related]
29. Diabetes promotes invasive pancreatic cancer by increasing systemic and tumour carbonyl stress in Kras
Menini S; Iacobini C; de Latouliere L; Manni I; Vitale M; Pilozzi E; Pesce C; Cappello P; Novelli F; Piaggio G; Pugliese G
J Exp Clin Cancer Res; 2020 Aug; 39(1):152. PubMed ID: 32778157
[TBL] [Abstract][Full Text] [Related]
30. MEKK3 Sustains EMT and Stemness in Pancreatic Cancer by Regulating YAP and TAZ Transcriptional Activity.
Santoro R; Zanotto M; Carbone C; Piro G; Tortora G; Melisi D
Anticancer Res; 2018 Apr; 38(4):1937-1946. PubMed ID: 29599309
[TBL] [Abstract][Full Text] [Related]
31. YAP and TAZ Negatively Regulate Prox1 During Developmental and Pathologic Lymphangiogenesis.
Cho H; Kim J; Ahn JH; Hong YK; Mäkinen T; Lim DS; Koh GY
Circ Res; 2019 Jan; 124(2):225-242. PubMed ID: 30582452
[TBL] [Abstract][Full Text] [Related]
32. Insulin Receptor and GPCR Crosstalk Stimulates YAP via PI3K and PKD in Pancreatic Cancer Cells.
Hao F; Xu Q; Zhao Y; Stevens JV; Young SH; Sinnett-Smith J; Rozengurt E
Mol Cancer Res; 2017 Jul; 15(7):929-941. PubMed ID: 28360038
[TBL] [Abstract][Full Text] [Related]
33. Neratinib inhibits Hippo/YAP signaling, reduces mutant K-RAS expression, and kills pancreatic and blood cancer cells.
Dent P; Booth L; Roberts JL; Liu J; Poklepovic A; Lalani AS; Tuveson D; Martinez J; Hancock JF
Oncogene; 2019 Jul; 38(30):5890-5904. PubMed ID: 31253872
[TBL] [Abstract][Full Text] [Related]
34. GNAS
Ideno N; Yamaguchi H; Ghosh B; Gupta S; Okumura T; Steffen DJ; Fisher CG; Wood LD; Singhi AD; Nakamura M; Gutkind JS; Maitra A
Gastroenterology; 2018 Nov; 155(5):1593-1607.e12. PubMed ID: 30142336
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of DCLK1 down-regulates PD-L1 expression through Hippo pathway in human pancreatic cancer.
Yan R; Li J; Zhou Y; Yao L; Sun R; Xu Y; Ge Y; An G
Life Sci; 2020 Jan; 241():117150. PubMed ID: 31837335
[TBL] [Abstract][Full Text] [Related]
36. The clinical relevance of the Hippo pathway in pancreatic ductal adenocarcinoma.
Drexler R; Küchler M; Wagner KC; Reese T; Feyerabend B; Kleine M; Oldhafer KJ
J Cancer Res Clin Oncol; 2021 Feb; 147(2):373-391. PubMed ID: 33098447
[TBL] [Abstract][Full Text] [Related]
37. Expression of the Hippo signalling effectors YAP and TAZ in canine mammary gland hyperplasia and malignant transformation of mammary tumours.
Rico C; Boerboom D; Paquet M
Vet Comp Oncol; 2018 Dec; 16(4):630-635. PubMed ID: 30117264
[TBL] [Abstract][Full Text] [Related]
38. Epithelial cell transforming 2 is regulated by Yes-associated protein 1 and mediates pancreatic cancer progression and metastasis.
Li C; Peng Z; Wang Y; Lam G; Nissen N; Tang J; Yuan X; Lewis M; Greene MI; Pandol SJ; Wang Q
Am J Physiol Gastrointest Liver Physiol; 2021 Mar; 320(3):G380-G395. PubMed ID: 33501895
[TBL] [Abstract][Full Text] [Related]
39. Pharmacological Activation of YAP/TAZ by Targeting LATS1/2 Enhances Periodontal Tissue Regeneration in a Murine Model.
Sato A; Suzuki S; Yuan H; Fahreza RR; Wang X; Nemoto E; Saito M; Yamada S
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674487
[TBL] [Abstract][Full Text] [Related]
40. Yap/Taz are required for establishing the cerebellar radial glia scaffold and proper foliation.
Hughes LJ; Park R; Lee MJ; Terry BK; Lee DJ; Kim H; Cho SH; Kim S
Dev Biol; 2020 Jan; 457(1):150-162. PubMed ID: 31586559
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
